Ipsilesional High Frequency Repetitive Transcranial Magnetic Stimulation Add-On Therapy Improved Diffusion Parameters of Stroke Patients with Motor Dysfunction: A Preliminary DTI Study

Table 1

Clinical data of included stroke patients.

Group	Number	Age (years)	Duration (days)	Gender	Lesion location	NIHSS		FM		BI
						Pre	Post	Pre	Post	Pre	Post
RT	1	72	5	F	L_IC, BG	8	5	10	42	50	60
	2	63	5	M	L_IC, BG	6	4	13	34	60	70
	3	79	3	M	L_IC, BG	10	6	38	69	35	55
	4	64	6	F	L_IC, BG	11	3	77	89	25	70
	5	64	6	F	L_IC, BG	11	9	67	77	25	30
	6	74	3	F	L_IC, BG	6	3	32	60	65	80
	7	58	4	M	L_IC, BG	9	5	22	51	25	45
	CT	8	56	4	F	L_IC	10	8	20	22	25	30
9		76	3	M	L_IC, BG, CR	5	3	60	64	50	65
10		53	6	F	L_IC, BG	9	7	14	35	40	55
11		75	7	M	L_IC, BG	10	7	40	41	25	50
12		61	5	F	L_IC, BG	9	6	22	27	30	40
13		67	5	F	L_IC, BG, CR	7	3	63	69	80	90
14		77	4	M	L_IC, BG, CR	11	5	11	18	20	30
15		68	6	M	L_IC, BG	5	3	20	24	60	70

BG: basal ganglia; BI: Barthel Index; CT: conventional treatment; CR: corona radiate; FM: Fugl-Meyer Assessment; L_IC: left internal capsule; NIHSS: National Institutes of Health Stroke Scale; RT: repetitive transcranial magnetic stimulation treatment; represents the significant difference between preclinical and postclinical scores (); △ represents the significant difference between the clinical scores of RT and CT groups.